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ABSTRACT
Introduction A key contributor to underimmunisation 
is parental refusal or delay of vaccines due to 
vaccine concerns. Many clinicians lack confidence in 
communicating with vaccine- hesitant parents (VHP) and 
perceive that their discussions will do little to change 
parents’ minds. Improving clinician communication with 
VHPs is critical to increasing childhood vaccine uptake.
Methods and analysis We describe the protocol for a 
cluster randomised controlled trial to test the impact of 
a novel, multifaceted clinician vaccine communication 
strategy on child immunisation status. The trial will 
be conducted in 24 primary care practices in two US 
states (Washington and Colorado). The strategy is called 
Presumptively Initiating Vaccines and Optimizing Talk with 
Motivational Interviewing (PIVOT with MI), and involves 
clinicians initiating the vaccine conversation with all 
parents of young children using the presumptive format, 
and among those parents who resist vaccines, pivoting to 
using MI. Our primary outcome is the immunisation status 
of children of VHPs at 19 months, 0 day of age expressed 
as the percentage of days underimmunised from birth to 
19 months for 22 doses of eight vaccines recommended 
during this interval. Secondary outcomes include clinician 
experience communicating with VHPs, parent visit 
experience and clinician adherence to the PIVOT with MI 
communication strategy.
Ethics and dissemination This study is approved by the 
following institutional review boards: Colorado Multiple 
Institutional Review Board, Washington State Institutional 
Review Board and Swedish Health Services Institutional 
Review Board. Results will be disseminated through peer- 
reviewed manuscripts and conference presentations.
Trial registration number NCT03885232.
INTRODUCTION
The reduction of vaccine- preventable diseases 
(VPD) is a top public health goal.1 Vaccine 
hesitancy, defined as a state of indecision and 
reluctance that results in a desire to defer or 
omit any routinely recommended vaccines, is 
a major barrier to achieving this goal and was 
recently declared as one of the top 10 threats 
to global health by the WHO.2 Parental refusal 
or delay of childhood vaccines has been asso-
ciated with increased odds of VPD3–5 as well 
as higher inpatient admission and emergency 
department utilisation rates.6 Therefore, 
there is renewed emphasis on sustaining and 
improving childhood vaccine coverage.7 8
A key influence on vaccine decision- making 
among vaccine- hesitant parents (VHP) is their 
child’s clinician.9 VHPs consider their child’s 
clinician to be a key information source in 
their decision- making about vaccines and 
their child’s health.10–14 Indeed, initially hesi-
tant parents reported changing their mind 
about delaying or refusing a vaccine after 
Strengths and limitations of this study
 ► This study uses a robust design to minimise con-
tamination as well as selection, ascertainment and 
participant biases.
 ► The trial setting of 24 primary care practices across 
two US states facilitates generalisability and will 
provide a knowledge base for how an interven-
tion can be integrated within a real- world practice 
setting.
 ► In measuring fidelity, it is possible to assess how our 
study results are attributable to clinician communi-
cation behaviour.
 ► We will not be able to assess the impact of the inter-
vention beyond 19 months of age.
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their child’s clinician addressed their concerns, provided 
them with additional information or gave them reassur-
ance.13 14 Consequently, how clinicians discuss and recom-
mend vaccines is important. For instance, the quality and 
presence of a clinician’s recommendation has been asso-
ciated with increased uptake of childhood and adolescent 
vaccines.15–25 Moreover, the communication format used 
to initiate the vaccine recommendation is influential: a 
presumptive (eg, ‘We have to do some shots’) rather than a 
participatory (eg, ‘How do you feel about vaccines today?’) 
format has been associated with increased parental accep-
tance of childhood and adolescent vaccines.26–28 Even 
among VHPs, significantly fewer verbally resisted vaccine 
recommendations when clinicians used a presumptive (vs 
participatory) format.26
A presumptive initiation format, however, is not 
always sufficient as some parents still voice resistance 
to vaccines even if the vaccine recommendation is initi-
ated presumptively. In addition, many clinicians lack 
confidence in communicating with parents who voice 
substantial vaccine concerns.29 To address these barriers, 
the feasibility and efficacy of using Motivational Inter-
viewing (MI) with VHPs has been explored. MI is a well- 
established, evidence- based, patient- centred framework 
for behaviour change30–47 that is effective even when 
delivered in a single session.33 41 MI’s three essential 
elements—having a conversation, leveraging inherent 
motivation for behaviours and making the conversation 
person centred—make it well adapted for use with VHPs 
given their known communication preferences regarding 
vaccines.10 14 In a large randomised controlled trial 
(RCT), clinician use of MI in discussions with parents 
who verbally resisted the HPV vaccine recommenda-
tion resulted in increased HPV vaccine acceptance and 
improved clinician perceptions of their ability to influ-
ence parental vaccine decision- making.48
This manuscript describes the protocol for a cluster 
RCT (cRCT) to evaluate the effect of a novel clini-
cian communication strategy that combines use of the 
presumptive initiation format and MI—the Presumptively 
Initiating Vaccines and Optimizing Talk with Motivational 
Interviewing (PIVOT with MI) intervention—on child 
immunisation status as well as on parent and clinician 
experience.
Conceptual model
The PIVOT with MI intervention is grounded in a concep-
tual framework by Resnicow et al called the ‘Difficulty by 
Motivation’ matrix (figure 1).49 This matrix, which can be 
applied to both health behaviours and health behaviour 
interventions, parses behaviours or interventions into four 
quadrants. Quadrants represent properties of the health 
behaviour or intervention being considered (x- axis) and 
individual- level factors, including motivation and/or 
competence to comply with the recommended behaviour 
or intervention (y- axis). Vaccination can be categorised 
as a simple health behaviour given it is an intervention 
with a high certainty of low risk and high benefit. Vaccine- 
accepting parents reside in the upper left quadrant given 
their high motivation to comply with vaccination. Inter-
ventions to promote compliance with vaccination simply 
need to match this motivation, such as using a presump-
tive format for initiating the vaccine recommendation 
that leverages vaccination as a normative behaviour. In 
contrast, VHPs reside in the lower left quadrant, having 
high resistance and low motivation to comply. As such, 
interventions to promote vaccination among VHPs need 
to be more robust. Following a presumptive vaccine 
recommendation, VHPs who verbally resist vaccination 
signal to the clinician that the parent is in need of a more 
intense intervention. This recognition can serve as a 
‘pivot point’ that triggers the clinician to shift from the 
presumptive recommendation to MI in order to leverage 
parents' intrinsic motivations for doing what they perceive 
is best for their children.
Aim and hypothesis
The main objective of this study is to evaluate the effect 
of the PIVOT with MI intervention on the immunisation 
status of children of VHPs using a pragmatic cRCT study 
design. We hypothesise that children of VHPs at interven-
tion practices will be less underimmunised than those at 
control practices.
METHODS AND ANALYSIS
A summary of the trial’s specifications is presented in 
table 1.
Study design and registration
This study is a two- arm cRCT with longitudinal follow- up. 
Study arms include a control arm, in which clinicians 
practise usual care, and an intervention arm, in which 
clinicians use the PIVOT with MI communication strategy 
with parents. This study is registered with  ClinicalTrials. 
gov (table 1).
Figure 1 Difficulty by motivation matrix. PIVOT with MI, 
Presumptively Initiating Vaccines and Optimizing Talk with 
Motivational Interviewing; VHP, vaccine- hesitant parent.
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Study overview and setting
We will randomise 24 primary care paediatric practices 
in two US states (Washington and Colorado) to control 
and intervention arms. Practices will be initially identified 
through two regional practice- based research networks 
in each state. Both states are ideal settings to conduct a 
study of an intervention designed to improve immunisa-
tion rates among VHPs, with each ranking in the highest 
quintile among US states in 2016 with respect to the 
proportion of parents claiming non- medical exemptions 
for their child from required school entry vaccines.50
Eligible parents will be identified through a screening 
survey administered at a visit prior to their children’s 
2- month health supervision visit. Clinicians at interven-
tion practices will receive training on the PIVOT with MI 
communication strategy. Clinicians at control clinics will 
give usual care, denoting that they will not receive any 
communication training and will continue to communi-
cate with parents about childhood vaccines as they are 
accustomed. A subset of enrolled parents at intervention 
and control clinics will have their children’s health super-
vision visits with participating clinicians videotaped to 
assess clinician–parent vaccine communication practices, 
including adherence to the PIVOT with MI communica-
tion strategy among intervention clinicians (ie, interven-
tion fidelity). Our main outcome is child immunisation 
status at 19 months expressed as the percentage of days 
underimmunised from birth to 19 months.
Study population and inclusion/exclusion criteria
All English and Spanish- speaking parents ≥18 years old 
with an infant ≤2 months old receiving health supervision 
at a participating practice during the enrolment period 
of August 2019 through March 2021 are eligible. VHPs 
will constitute our primary study population because 
changing the vaccination behaviour of these parents is of 
utmost interest.51 52 VHPs are defined as those with a posi-
tive score on the short form of the Parent Attitudes about 
Childhood Vaccine (PACV- SF) survey, a validated survey 
to identify VHPs.53–55
Consent and recruitment
The PACV- SF will be placed in participating practices’ 
standard intake paperwork and administered on check- in 
an infant’s health supervision visit between birth and 
age 2 months. The survey will be embedded in a larger 
questionnaire to minimise ascertainment bias and will 
include instructions that contain information to ensure 
that parents are fully informed, including that survey 
completion is voluntary, for research purposes, and that 
participation in the study will involve access of children’s 
immunisation record data. Parents who complete the 
survey will be considered enrolled and remain active in 
the study until their child turns 19 months of age.
We will obtain a waiver of documentation of written 
consent because parent participation consists primarily 
of information collected in a survey, and therefore 
Table 1 PIVOT with MI trial specifications
Data category Information
Registry and trial number ClinicalTrials.gov: NCT03885232
Date of registration 21 March 2019
Secondary identifying 
numbers
17–1274
Financial support Eunice Kennedy Shriver National Institute of Child Health and Development at the US National 
Institutes of Health; PO Box 3006, Rockville, MD 20847
Contact for queries douglas.opel@seattlechildrens.org
Title Evaluation of the Presumptively Initiating Vaccines and Optimizing Talk with Motivational 
Interviewing (PIVOT with MI) Intervention
Countries of recruitment USA
Health condition studied Infant vaccination
Intervention(s) Active comparator: clinician vaccine communication strategy
Passive comparator: usual care
Key inclusion and exclusion 
criteria
Inclusion: ≥18- year- old parent with child ≤2 months old who receives health supervision at 
participating practice. Exclusion: parent who is <18 years old or has child >2 months old who 
receives health supervision at a participating practice
Study type Cluster randomised controlled trial
Date of first enrolment 27 September 2019
Target sample size 600 vaccine- hesitant parents
Trial status Ongoing data collection
Primary outcomes Percentage of days undervaccinated of child at 19 months of age
Key secondary outcomes Parent visit experience; clinician self- efficacy; clinician adherence to PIVOT with MI 
communication strategies
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completion of the survey is considered consent to partic-
ipate. However, in participating practices in Washington 
State, a study information sheet that includes all elements 
of consent will be attached to the PACV- SF and parents’ 
signatures will be required to access immunisation records 
of children in the Washington State Immunization Infor-
mation System (WAIIS).
For the fidelity substudy, study staff will approach 
enrolled English- speaking VHPs who answered an item 
on the PACV- SF affirmatively that asks for their permis-
sion to contact them via phone or email to determine 
their interest in participating in the substudy. We will 
describe the study to parents in general terms as a study 
in which we videotape their child’s visit to assess how 
doctors and parents communicate at child check- ups in 
order to minimise the chance that parents alter their 
immunisation- related behaviour during the videotaped 
visit to meet observer expectations. Interested VHPs will 
meet study staff at an upcoming health supervision visit 
that their children have with participating clinicians to 
obtain parents’ written informed consent. Participating 
clinicians will also provide written informed consent to 
be videotaped.
Assignment of intervention
Practices are the unit of randomisation. A key issue in 
cRCTs is the possibility of covariate imbalance in practices 
assigned to different treatment arms.56–60 Thus, practices 
will be randomly assigned by one analyst (MD) based 
on specific covariates that are potential confounders 
to assure balanced comparison groups using optimised 
probability sampling to the intervention or control arm 
using covariate- constrained randomisation. From the 24 
practices that agree to participate in the study, prestudy 
information will be collected on several variables that may 
influence study outcomes: per cent of VHPs, per cent of 
Vaccines for Children- eligible patients, number of paedi-
atric clinicians and proportion of participating clinicians 
who currently use the presumptive initiation format. Each 
variable will be used to develop and evaluate a balance 
criterion, defined as the sum of the squared differences 
between standardised practice means on these variables.57 
All possible combinations of eligible practices in inter-
vention and control arms will be generated using a SAS 
macro program (SAS version 9.4; SAS Institute Inc., Cary, 
NC, USA).59 The distribution of the balance criterion for 
the two study arms will be used to define an acceptable 
set of study arms that are reasonably balanced in terms 
of the selected variables (minimum 10% of balance crite-
rion).57 From this set, one set will be chosen at random 
and used to randomly assign each practice to interven-
tion or control arm. The process of randomisation will 
be undertaken separately among the 12 Colorado and 
12 Washington practices and will occur prior to parent 
enrolment.
Blinding
Given our intervention, it is not possible to blind prac-
tices or investigators to study arm allocation; however, our 
analysts will be blinded. We will minimise selection bias by 
approaching all parents whose newborns receive health-
care at participating practices and by including those who 
complete the PACV- SF survey in the study and analysis. 
We will minimise participant bias by blinding clinicians at 
participating practices to PACV- SF scores of parents and 
parent ascertainment bias by embedding the PACV- SF in 
a larger survey.
Sample size calculation
Primary outcome
Based on preliminary data, children of VHPs have a mean 
percentage of days underimmunised of 26.2% (SD 29.8) 
from birth to 19 months of age for six vaccines combined 
(hepatitis B, diphtheria, tetanus and acellular pertussis 
(DTaP), Haemophilus influenzae type b (Hib), inactivated 
polio virus (IPV), measles, mumps and rubella (MMR) 
and varicella).55 In order to have adequate power (≥90%) 
to detect a decrease of seven percentage points in days 
underimmunised (26% to 19%), we plan to enrol 600 
VHP/newborn pairs total with 300 per arm (assuming an 
α of 0.05, an SD of 20 and an intraclass correlation coef-
ficient for within- clinic correlation of 0.02).29 This effect 
size of seven percentage points in days underimmunised 
corresponds to a clinically meaningful decrease in days 
late per vaccine dose to within the 30- day window in 
which most vaccine doses are recommended.61 Assuming 
a 10% prevalence of VHPs,29 we will need to approach 
6000 parents to reach our sample size goal (ie, 5400 of 
parents will be non- VHPs). This is feasible in our planned 
18- month enrolment period given our design to integrate 
PACV- SF screening of parents of newborns into standard 
workflow and our estimate of ≥10 newborns per clinic per 
week in participating practices. If we vary our assumptions 
regarding VHP prevalence (7.5%) or SD (25), we would 
need to approach 8000 and 12 000 parents, respectively, 
for adequate (≥90%) power to detect the same effect size, 
both of which remain feasible within the 18- month enrol-
ment period assuming ≥10 newborns per clinic per week.
Secondary outcomes
Since our fidelity outcome is based on a qualitative 
study design, power is not appropriate. However, based 
on our past work,26 27 we believe we will achieve suffi-
cient behavioural variation across clinicians to develop a 
coding scheme with three videotaped visits per clinician. 
We will therefore videotape 360 encounters (180 in each 
state), which averages to three videotaped encounters per 
practice clinician.
For the parent visit experience outcome, we will have 
80% power to detect a 13 percentage point difference in 
the proportion of parents who rate their visit experience 
highly between study arms if we enrol 312 VHPs (156 per 
arm) assuming a baseline proportion of 72% of parents 
who rate their visit experience highly27 and equal distri-
bution of participants in control and intervention prac-
tices. For clinician outcomes, we will have 80% power to 
detect a 12 percentage point pre- post difference between 
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control (one percentage point pre- post difference) and 
intervention clinicians (13 percentage point pre- post 
difference), assuming 60 clinicians in each arm. Overall, 
this number of clinicians per arm seems feasible since we 
anticipate the study will involve >120 total clinicians (five 
to seven clinicians per practice).
Intervention
The PIVOT with MI intervention involves the combina-
tion of two evidence- based vaccine communication strat-
egies in a tiered approach: use of the presumptive format 
to initiate the childhood vaccine recommendation with 
all parents followed by use of MI if a parent verbally 
resists the recommendation. To train clinicians to use 
the PIVOT with MI communication strategy, we devel-
oped a multifaceted curriculum62–64 that includes several 
approaches based on adult learning theory65 previously 
found to be effective in changing clinician behaviour.66 67 
These approaches include interactive and tailored educa-
tional outreach,68 clinician rehearsal and coaching,69 
audit and feedback,70 booster learning sessions69 and 
change agents.71 Given our intent to also have PIVOT 
with MI implemented with Spanish- speaking parents, the 
PIVOT with MI intervention draws on evidence for cultur-
ally adapting behavioural interventions in community 
settings.72 73 We obtained iterative input from clinicians 
at primary care paediatric practices not participating in 
the trial on the format, length, and content of the PIVOT 
with MI intervention components (table 2).
Outcomes
Our primary outcome will be the immunisation status of 
children of VHPs at 19 months, 0 day of age expressed 
as the percentage of days underimmunised from birth to 
19 months for 22 doses of eight vaccines recommended 
during this interval (3 hepatitis B, 3 rotavirus, 4 DTaP, 
3 Hib, 4 pneumococcal conjugate, 3 IPV, 1 MMR and 
1 varicella). To calculate the percentage of days under-
immunised, we will sum the days late for each dose and 
divide this by the maximum number of days a child could 
be late if they had received none of the total 22 doses for 
the eight vaccines by 19 months. We have chosen to use 
the percentage of days underimmunised because it is a 
sensitive measure of underimmunisation by accounting 
for missed vaccine doses and delay in receipt of vaccines.74 
Our secondary outcomes include (A) adherence to 
PIVOT with MI communication techniques assessed via 
videotaping of health supervision visits, (B) parent visit 
experience assessed via a 15- item paper survey after a 
health supervision visit, and (C) clinician experience 
communicating with parents about vaccines (including 
time spent discussing childhood vaccines with typical 
parents and with parents who have substantial vaccine 
concerns) assessed via a paper or web- based survey before, 
during and after the parent enrolment period.
Data collection methods
Parents will complete the PACV- SF embedded within a 
survey on child health topics at enrolment. This survey will 
also include demographic items that have been associated 
with underimmunisation (parent age, childbirth order, 
household income, marital status, parent self- designated 
race/ethnicity, gender and number of children in their 
household) as well as permission for study staff to contact 
them for future studies if interested. For enrolled VHPs 
Table 2 PIVOT with MI intervention components
Intervention component Description
Online video module Introduces the PIVOT with MI communication strategy and its rationale.
One 60 min in- person 
interactive clinician training 
session
Includes (A) a brief didactic session on vaccine hesitancy, how the PIVOT with MI strategy 
addresses vaccine hesitancy, and practice data on vaccination coverage and vaccine hesitancy 
prevalence, (B) baseline assessments of clinician skills using the presumptive format and MI, 
and (C) modelling of elements of the PIVOT with MI intervention followed by clinician rehearsal 
through role- playing and coaching by the study team. An online version of this session is 
available when clinicians are unable to attend the in- person session.
Reference sheets Provides brief and accessible summaries of the communication behaviours that comprise 
PIVOT with MI, along with example statements for key steps in the PIVOT with MI 
communication strategy.
Two 30–60 min in- person 
refresher trainings at 3–6 and 
9–12 months after the start of 
the intervention
Includes a question and answer session regarding barriers to implementing the PIVOT with MI 
intervention followed by role- playing and coaching, with the 9–12 months of refresher training 
also including a review of videotaped encounters of intervention clinicians with VHPs to provide 
feedback for how to improve incorporation of PIVOT with MI into the vaccine discussion. Online 
versions of these sessions are available when clinicians are unable to attend the in- person 
sessions.
Practice study champion Will routinely solicit feedback from intervention clinicians regarding the PIVOT with MI 
intervention and liaise with the study team at regular intervals to communicate and help address 
implementation issues.
MI, Motivational Interviewing; PIVOT with MI, Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing; VHP, 
vaccine- hesitant parent.
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who provide permission, study staff will contact them via 
phone and/or email to assess their willingness to partici-
pate in the fidelity substudy. Parents and clinicians will be 
given the right to review the videotape after the visit and 
delete any or all portions. We will administer a 15- item 
visit experience paper survey to all VHPs immediately 
after the videotaped visit.
Intervention and control clinicians will complete a 
paper or web- based survey regarding their experience 
communicating with parents about vaccines. Clinicians 
will complete a survey at baseline prior to randomisation 
and parent enrolment, at an interim time point during 
the study period and at a final time point after parent 
enrolment is completed.
We will obtain immunisation data from WAIIS and 
the Colorado Immunization Information System (CIIS). 
Enrolled children’s medical records will serve as a 
secondary immunisation data source. WAIIS and CIIS 
operate in accordance with nationally recommended 
standards for immunisation registries, and all enrolled 
practices participate in CIIS or WAIIS. Both CIIS and 
WAIIS use birth certificate data to identify children and 
cover ≥95% of children <6 years old in their respective 
states.75 Both CIIS and WAIIS76 combine the immunisa-
tion information from multiple sources into a consol-
idated, complete and valid record of immunisations. 
Data quality assessments are done frequently. Offices are 
required to have <5% error rate in the registry, making 
these registries a highly accurate data source for assessing 
vaccine utilisation.
Participant retention
Retention of parent participants is facilitated by our 
study design. Specifically, parent participation in the 
overall study is limited to completing a survey at enrol-
ment. Parent participation in the fidelity substudy is 
limited to a single videotaped encounter and comple-
tion of a short visit experience survey. To assist with 
parent retention in the fidelity substudy, parents will 
receive a $25 gift card after completing the visit experi-
ence survey.
Retention of participating clinicians in the practices 
is aided by receipt of Maintenance of Certification 
(MOC) Part 4 credit from the American Board of Pedi-
atrics. To receive MOC, clinicians will need to complete 
the entire PIVOT with MI curriculum. MOC will be 
provided to clinicians at practices randomised to the 
intervention arm during the study and to clinicians at 
practices randomised to the control arm who complete 
the PIVOT with MI curriculum at the conclusion of the 
study. Participating clinicians who complete all surveys 
at baseline, interim and poststudy will also receive a $25 
gift card.
Data security and storage
To ensure confidentiality and protection of the data, we 
will use several data security measures (box 1).
Statistical methods
We will examine baseline characteristics of parents and 
clinicians by study arm using Pearson’s χ2 tests (or Fisher’s 
exact tests) for categorical variables and t- tests for contin-
uous variables to assess for any unbalanced confounders. 
Any unbalanced confounders will be controlled for as 
covariates in all subsequent regression analyses. Given the 
nested structure of the data, we will apply mixed effects 
regression models to examine the effects of the interven-
tion on our primary outcome while controlling for covari-
ates and accounting for correlations due to clustering.
To analyse the videotaped data for our fidelity substudy, 
we will use conversation analysis (CA) with a subset of 
the videotaped encounters to develop a coding scheme 
to assess adherence to PIVOT with MI communication 
techniques. CA is an analytical technique that searches 
for patterns in the clinician–parent interaction that are 
systematically used to accomplish a social action either 
vocally or non- vocally.77 Multiple coders from the study 
team will be trained on the coding scheme using 10% of 
the videotaped data. We will measure inter- rater reliability 
between the coders using up to an additional 20% of the 
data until κ scores reach a minimum of 70. Coders will 
then independently code all remaining data (and recode 
the initial 10% of training data).
Given the skewed distribution parent visit experi-
ence data, we will use two dichotomisation methods 
to summarise parent visit experience: the top box 
method,78–81 consistent with Consumer Assessment of 
Healthcare Clinicians and Systems survey scoring,82 and 
an alternative method83–85 in which an average score of 
≥6 (out of 7) on each of the 15 items is indicative of a 
highly rated visit experience.27 We will also summarise 
Box 1 Data security and storage practices
1. Health Insurance Portability and Accountability Act (HIPAA) require-
ments will be adhered to as required by the law.
2. Each parent/child participant in the study will have a unique study 
ID and all linkages between study IDs and individual- level data will 
be destroyed on completion of the study.
3. Deidentified data will be placed on a secure password- protected file 
transfer protocol server.
4. Data will be stored at Seattle Children’s Research Institute (SCRI) 
and University of Colorado Denver (UCD) where access is limited 
to SCRI and UCD study staff, with data backed up automatically at 
least nightly.
5. We will maintain each data set separately and index the records 
using unique encrypted identifiers to facilitate linkages between 
files while maintaining confidentiality of personal health information.
6. All videotaped data will be kept in a locked storage area at SCRI 
and UCD; no one outside the research team will have access to the 
videotaped data.
7. Videotaped data will be sent to coinvestigators at outside institu-
tions using a HIPAA compliant online data storage server.
8. The analysis of this videotaped data done at these outside institu-
tions will be done on password- protected computers with access 
restricted to research team members. Library-S
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parent experience as a continuous variable. We will use 
Pearson’s χ2 test to compare parent (binary) ratings of 
visit experience between control and intervention arms. 
We will apply mixed effects logistic regression model to 
account for within- clinic correlation and any unbalanced 
confounding factors. When summarising parent expe-
rience as a continuous variable, we will apply Box- Cox 
transformation if it is highly skewed and linear mixed 
effects models to examine differences between control 
and intervention arms.
To summarise clinician experience, we will compare 
the baseline, interim and postintervention proportions 
of control and intervention clinicians on (1) time spent 
discussing vaccines at a typical visit and during visits with 
VHPs; (2) use of presumptive and/or MI techniques 
in vaccine discussions with families; and (3) reported 
ability to influence parents’ vaccine decisions. We will use 
Pearson’s χ2 test in unadjusted analyses of the pre- post 
differences between control and intervention arms and 
multivariable logistic regression for adjusted analyses that 
control for potential confounders such as clinician demo-
graphic and practice characteristics. Models will account 
for clustering of outcomes by practices where needed.
Analytical framework
For our primary outcome, we will conduct an intention- 
to- treat analysis with the patient as the unit of analysis. 
This analytical cohort will include all enrolled VHPs/
child dyads with child immunisation data at 19 months 
of age. For clinician and parent experience outcomes, 
we will conduct a modified intention- to- treat analysis that 
includes all clinicians and VHPs with a completed survey.
Missing data
We will assess the amount of missing data and missing data 
mechanism. We will apply Little’s test to check if data are 
missing completely at random (MCAR).86 We will assess 
baseline characteristics by missing data as well as missing 
outcome data by study arm to evaluate MCAR assump-
tions. We will apply sensitivity analyses and multiple impu-
tation techniques to address missing data.
Subgroup analyses
Planned subgroup analyses include examining clinician 
experience outcomes by practice type, %VHPs in the 
practice and practice size.
Monitoring
The principal investigators (PI) of this study (SOL and 
DJO) will have overall responsibility for participant safety 
monitoring. However, oversight for data safety and moni-
toring of the study will be conducted by a faculty member 
at University of Colorado Denver (UCD) who is not 
involved in the project. In this capacity, this individual 
will provide independent observation and verification 
of protocol compliance, recruitment and study progress, 
and data completeness. This will be done through corre-
spondence with the PIs and by reviewing draft annual 
reports on these parameters provided by the study team. 
This individual will also monitor the study for adverse 
events, and the study team’s response to these events, 
should any occur. A letter summarising findings will 
be included in the finalised annual project reports for 
National Institutes of Health. Though adverse events are 
not anticipated, they will be reported to all involved insti-
tutional review boards at the time of the event, should 
any occur.
Assessment of harms and adverse events
The risks for this behavioural intervention are minimal. 
All participating practices will be regularly reminded via 
interactions with study champions to promptly report all 
adverse events to the PIs or designated study representa-
tive. Study participants will also be encouraged to contact 
the research team with any concerns and will be given the 
team’s contact information at enrolment.
ETHICS AND DISSEMINATION
This study is approved by the Colorado Multiple Institu-
tional Review Board, the Washington State Institutional 
Review Board and the Swedish Health Services Institu-
tional Review Board.
Informed consent
Parents who complete the enrolment survey will be 
considered to have consented to participate. This enrol-
ment survey will contain information about the study and 
its risks and benefits (online supplementary material). 
Written informed consent will be obtained from VHPs 
and clinicians who participate in the fidelity substudy.
Access to data
Access to data will be limited to the Seattle Children’s 
Research Institute and UCD research teams. Access to a 
deidentified, aggregated version of the data set and anal-
ysis code will be available on request with approval by the 
research team.
Dissemination plans
Study materials will be developed so that they may be 
easily adapted to other settings, with particular focus on 
having the online video training module available for use 
by others immediately. In addition, should this interven-
tion prove effective, we intend to collaborate with two US 
practice- based research networks to test the intervention 
on a broader scale. Results of the study will be presented 
at national and international research conferences and 
through peer- reviewed publications.
Patient and public involvement
Patients involved in this study are children under age 2 
and are only involved in this study as research partici-
pants. Parents of child participants will not be involved 
in recruitment, data analysis or dissemination. Clinicians 
will be involved in the refinement of the PIVOT with MI 
intervention.
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